Antibodies News and Research

RSS

Slow-release HIV vaccine shows promise in preclinical trials

A new slow-release vaccine has been shown to boost the immune system’s response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.

10 May 2019

Experts find previously unknown bacterial strain of the genus Leptospira

Experts from MedUni Vienna/Vienna General Hospital have identified a previously unknown bacterial strain of the genus Leptospira.

8 May 2019

Human iPSCs make more tiny 'cargo packets' to deliver cellular aging therapies

Johns Hopkins scientists report that adult cells reprogrammed to become primitive stem cells, called induced pluripotent stem cells, make tiny "cargo packets" able to deliver potentially restorative or repairing proteins, antibodies or other therapies to aged cells.

From Johns Hopkins Medicine 8 May 2019

Groundbreaking research could lead to a simple, inexpensive test for Ebola virus

In a breakthrough that could lead to a simple and inexpensive test for Ebola virus disease, researchers have generated two antibodies to the deadly virus.

7 May 2019

Research aims to keep astronauts healthy in space

Falling ill while traveling is an unfortunate yet common occurrence. Even a minor bug can ruin an entire trip. But for astronauts, getting sick on a long space voyage would have far more serious consequences than a little spoiled fun.

7 May 2019

Researchers develop a new approach to targeting tumors and metastases

The spread of malignant cells from an original tumor to other parts of the body, known as metastasis, is the main cause of cancer deaths worldwide.

7 May 2019

Aptamer Therapeutics collaborates with Cancer Research UK for drug development program

Following the successful awarding of a CRUK Biotherapeutic Drug Discovery Project Award, Aptamer Therapeutics Limited, part of Aptamer Group, is pleased to announce a new collaboration with Dan Wiseman and the Oglesby Leukemia Research Program at the University of Manchester and Cancer Research UK.

From Aptamer Group 6 May 2019

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder.

3 May 2019

New two-tier method can enable early-stage detection of Alzheimer’s

Using current techniques, Alzheimer's disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain.

3 May 2019

Scientists unravel mechanism of action of antitumor drug used to treat glioblastoma

Glioblastoma is an incurable type of brain tumor that is frequently associated with mutations in the epidermal growth factor receptor.

3 May 2019

Innovative treatment improves vision of a patient suffering from melanoma-associated retinopathy

Innovative treatment has improved the vision of a patient suffering from a rare cancer-related syndrome affecting the eye, new research in the journal JAMA Ophthalmol reports.

30 Apr 2019

Summer bummer: A young camper’s $142,938 snakebite

It was dusk as Oakley Yoder and the other summer camp kids hiked back to their tents at Illinois' Jackson Falls last July. As the group approached a mound of boulders blocking the path, Oakley, then 9, didn't see the lurking snake — until it bit a toe on her right foot.

30 Apr 2019

Study identifies antigens targeted by antibody response to Kawasaki Disease

A new study identifies antigens targeted by the antibody response of children with Kawasaki Disease.

29 Apr 2019

TET proteins help regulate gene activity vital for normal antibody production

A family of cancer suppressive proteins, known as TET proteins, help regulate gene activity via their influence on chromosomal architecture. However, until now it wasn't entirely clear how genes were activated by TET proteins to make sure that cells perform their normal functions efficiently.

27 Apr 2019

Researchers succeed in humanization of mouse antibodies targeting human herpesvirus 6B

A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.

26 Apr 2019

New sepsis detector uses photonics to make accurate diagnosis in less than thirty minutes

European scientists have developed a new sepsis detector that uses photonics to produce a while-you-wait diagnosis, from sample to result, in less than thirty minutes.

24 Apr 2019

DNA rearrangement may predict poor outcomes in multiple myeloma

A certain type of DNA marker predicts poor outcomes in multiple myeloma, researchers at Winship Cancer Institute, Emory University have found.

24 Apr 2019

UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

University of Alabama at Birmingham researchers will receive $17.8 million in federal funding to attack a key "knowledge gap" in human immunology -- how the B cells and antibody-secreting cells that reside in tissues and organs differ from those found in blood.

23 Apr 2019

Researchers identify new allergen responsible for allergy to durum wheat

An international team of researchers, in which a female researcher from Universidad Politécnica de Madrid is involved, has identified one of the main causes of food allergy in the Mediterranean area.

22 Apr 2019

Researchers discover why women get autoimmune diseases far more often than men

It's one of the great mysteries of medicine, and one that affects the lives of millions of people: Why do women's immune systems gang up on them far more than men's do, causing nine times more women to develop autoimmune diseases such as lupus?

22 Apr 2019

Antibodies News and Research

Slow-release HIV vaccine shows promise in preclinical trials

Experts find previously unknown bacterial strain of the genus Leptospira

Human iPSCs make more tiny 'cargo packets' to deliver cellular aging therapies

Groundbreaking research could lead to a simple, inexpensive test for Ebola virus

Research aims to keep astronauts healthy in space

Researchers develop a new approach to targeting tumors and metastases

Aptamer Therapeutics collaborates with Cancer Research UK for drug development program

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

New two-tier method can enable early-stage detection of Alzheimer’s

Scientists unravel mechanism of action of antitumor drug used to treat glioblastoma

Innovative treatment improves vision of a patient suffering from melanoma-associated retinopathy

Summer bummer: A young camper’s $142,938 snakebite

Study identifies antigens targeted by antibody response to Kawasaki Disease

TET proteins help regulate gene activity vital for normal antibody production

Researchers succeed in humanization of mouse antibodies targeting human herpesvirus 6B

New sepsis detector uses photonics to make accurate diagnosis in less than thirty minutes

DNA rearrangement may predict poor outcomes in multiple myeloma

UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

Researchers identify new allergen responsible for allergy to durum wheat

Researchers discover why women get autoimmune diseases far more often than men

Immunology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News